2026-04-29T06:15:43Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/230672024-11-29T14:06:11Zcom_20.500.12105_2173com_20.500.12105_2051col_20.500.12105_19597

00925njm 22002777a 4500 dc Alvarez, R author Musteanu, M author Garcia-Garcia, E author Lopez-Casas, P P author Megias, D author Guerra, Carmen author Muñoz, M author Quijano, Y author Cubillo, A author Rodriguez-Pascual, J author Plaza, C author de Vicente, E author Prados, S author Tabernero, S author Barbacid, Mariano author Lopez-Rios, F author Hidalgo, M author 2014-10-14 Br J Cancer . 2014 ;111(8):1677-8 https://hdl.handle.net/20.500.12105/23067 24642623 10.1038/bjc.2014.129 1532-1827 British journal of cancer Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.